Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Connolly

Showing results (971-980 of 1,370) with videos related to

Pageof 137
Sort By:
The New England Journal of Medicine|September 7, 2007
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutterBramah N Singh, Stuart J Connolly, Harry J G M Crijns, et al.
Stem Cells and Development|September 28, 2007
Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantationFeng Cao, Koen E A van der Bogt, Amir Sadrzadeh, et al.
Journal of Internal Medicine|October 19, 2017
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trialM Proietti, Z Hijazi, U Andersson, et al.
Open Heart|July 19, 2018
Efficacy and safety of dabigatran versus warfarin from the RE-LY trialAlvaro Avezum, Gustavo Bernardes de Figueiredo Oliveira, Rafael Diaz, et al.
International Journal of Cardiology|June 21, 2015
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trialMichela Brambatti, Harald Darius, Jonas Oldgren, et al.
Circulation|March 1, 2012
Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudyZiad Hijazi, Jonas Oldgren, Ulrika Andersson, et al.
Journal of Thrombosis and Thrombolysis|December 18, 2012
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?Brian Dale, John W Eikelboom, Jeffrey I Weitz, et al.
Circulation|March 22, 2000
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodaroneS J Connolly, M Gent, R S Roberts, et al.
JAMA|February 20, 2014
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trialCarlos A Morillo, Atul Verma, Stuart J Connolly, et al.
Journal of the American College of Cardiology|November 14, 1997
Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: randomized comparison of patient response criteriaL B Mitchell, R S Sheldon, A M Gillis, et al.
Pageof 137

Showing results (971-980 of 1,370) with videos related to

Sort By:
Pageof 137
The New England Journal of Medicine|September 7, 2007
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutterBramah N Singh, Stuart J Connolly, Harry J G M Crijns, et al.
Stem Cells and Development|September 28, 2007
Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantationFeng Cao, Koen E A van der Bogt, Amir Sadrzadeh, et al.
Journal of Internal Medicine|October 19, 2017
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trialM Proietti, Z Hijazi, U Andersson, et al.
Open Heart|July 19, 2018
Efficacy and safety of dabigatran versus warfarin from the RE-LY trialAlvaro Avezum, Gustavo Bernardes de Figueiredo Oliveira, Rafael Diaz, et al.
International Journal of Cardiology|June 21, 2015
Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trialMichela Brambatti, Harald Darius, Jonas Oldgren, et al.
Circulation|March 1, 2012
Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudyZiad Hijazi, Jonas Oldgren, Ulrika Andersson, et al.
Journal of Thrombosis and Thrombolysis|December 18, 2012
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?Brian Dale, John W Eikelboom, Jeffrey I Weitz, et al.
Circulation|March 22, 2000
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodaroneS J Connolly, M Gent, R S Roberts, et al.
JAMA|February 20, 2014
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trialCarlos A Morillo, Atul Verma, Stuart J Connolly, et al.
Journal of the American College of Cardiology|November 14, 1997
Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: randomized comparison of patient response criteriaL B Mitchell, R S Sheldon, A M Gillis, et al.
Pageof 137